GENC
Gencor Industries, Inc.
GENC has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over GENC overall, supported by stronger fundamentals and stronger modeled upside.
GENC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
GENC's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
GENC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $14.16 | -20% |
| Current | 17x | $17.62 | — |
| Fair | 18x | $18.30 | +3.9% |
| Expensive | 39x | $39.17 | +122% |
Historical ranges are pointers, not guarantees.
GENC's PE is in its fair range at 17x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
GENC Forward outlook
There aren't enough analyst estimates for GENC to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GENC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.01 | -2.9% |
| Q1 2026 | $0.88 | -7.4% |
| Q4 2025 | $1.04 | +9.5% |
| Q3 2025 | $1.07 | +8.1% |
| Q2 2025 | $1.04 | -5.5% |
| Q1 2025 | $0.95 | -17% |
| Q4 2024 | $0.95 | -10% |
| Q3 2024 | $0.99 | -1% |
GENC has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
GENC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.8M | +25% |
| Q1 2026 | $33.8M | -12% |
| Q4 2025 | $23.6M | -25% |
| Q3 2025 | $18.8M | -10% |
| Q2 2025 | $27M | +5.6% |
| Q1 2025 | $38.2M | -6.1% |
| Q4 2024 | $31.4M | +21% |
| Q3 2024 | $20.9M | +0.2% |
GENC's revenue is recovering but still below its 2024 peak: $34M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.5 points |
| Q1 2026 | 13% | -4.4 points |
| Q4 2025 | 13% | -1.6 points |
| Q3 2025 | -1.2% | -7.1 points |
| Q2 2025 | 12% | +3.8 points |
| Q1 2025 | 17% | -0.4 points |
| Q4 2024 | 15% | +1.7 points |
| Q3 2024 | 5.9% | -7 points |
GENC has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over GENC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
GENC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$17.2M | +$7.2M |
| Q1 2026 | $6.7M | -45% |
| Q4 2025 | $10.1M | -30% |
| Q3 2025 | -$1.3M | +$2M |
| Q2 2025 | -$24.4M | -$23M |
| Q1 2025 | $12.3M | +5.5% |
| Q4 2024 | $14.5M | +848% |
| Q3 2024 | -$3.3M | -130% |
GENC has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
GENC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | -0.6% | -91K shares |
| Available history | -0.3% | -50K shares |
GENC has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q3 2024 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
GENC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -2.7x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
GENC has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GENC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 48.4 | Neutral |
GENC's weekly RSI is 58 (neutral) and its Stochastic is 48 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
GENC PE vs Industrials Sector
| Metric | GENC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 28% below |
| PE % | 45 | 58 | 13 pts below |
GENC is trading at 17x earnings, a 28% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
GENC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.5 | 0.7% above |
| 20 week MA | $17.0 | 3.6% above |
| 50 week MA | $15.5 | 14% above |
| 100 week MA | $14.9 | 18% above |
| 200 week MA | $15.8 | 12% above |
GENC has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
GENC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.8 | $11.8 | 0% |
| 2021 | $11.8 | $11.6 | -1.6% |
| 2022 | $11.6 | $10.4 | -10% |
| 2023 | $10.4 | $16.1 | +55% |
| 2024 | $16.1 | $17.4 | +7.8% |
| 2025 | $17.4 | $12.6 | -28% |
| 2026 YTD | $12.6 | $17.6 | +40% |
GENC has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.